Hypocomplementemic urticarial vasculitis with angioedema, a rare presentation of systemic lupus erythematosus: Rapid response to rituximab Article

cited authors

  • Saigal, K; Valencia, IC; Cohen, J; Kerdel, FA

fiu authors


  • We report a case of hypocomplementemic urticarial vasculitis and recurrent angioedema in a patient with systemic lupus erythematosus unresponsive to mycophenolate mofetil, high-dose methylprednisolone, and intravenous immunoglobulin that responded rapidly to rituximab. Rituximab is a monoclonal antibody against CD20 transmembrane protein on the surface of mature and malignant B cells. No adverse effects occurred during or after therapy, and tbe patient was discharged from the hospital for outpatient rituximab infusion and follow-up care.

publication date

  • January 1, 2003

Digital Object Identifier (DOI)

start page

  • 283

end page

  • 285


  • 49


  • 5 SUPPL.